专利信息

首页 1 2 3 4 5 6 下页尾页共 146 条记录, 当前第1/15页。

专利标题：Solid pharmaceutical composition comprising telithromycin

专利权人：Aventis Pharma S.a.;

The invention relates to a novel solid pharmaceutical composition of telithromycin which facilitates swallowing by the patient.

专利标题：SOLID PHARMACEUTICAL COMPOSITION COMPRISING TELITHROMYCIN

专利权人：AVENTIS PHARMA SA [FR];

The invention relates to a novel solid pharmaceutical composition of telithromycin which facilitates swallowing by the patient.

专利标题：Method for the production and use of spherical telithromycin clusters in the preparation of pharmaceutical forms

专利权人：Aventis Pharma S.a.;

专利标题：A kind of compound telithromycin nanoemulsion oral liquid and preparation method thereof

专利权人：Northwest A&f University;

专利标题：Main invention of the solid medicine composition which

Solid pharmaceutical composition (A) comprises telithromycin (I) (0.1-80 wt.%) or its acid addition salts as an active ingredient and a diluting agent (II) (10-50 wt.%) having plastic behavior. - ACTIVITY : Antibacterial. - MECHANISM OF ACTION : None given.

专利标题：Amorphous telithromycin compound

专利权人：SANDOZ AG;

The present invention relates to stable amorphous 3-De[(26-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyl)oxy]-1112-dideoxy-6-O-methyl-3-oxo-1211-[oxycarbonyl[[4-[4-(3-pyridinyl)-1H-imidazol-1-yl]butyl]imino]]erythromycin (telithromycin) methods for the preparation thereof the use of stable amorphous telithromycin in the treatment of bacterial infections and to pharmaceutical compositions comprising stable amorphous telithromycin.

专利标题：Compound telithromycin nanoemulsion oral liquid and preparation method thereof

专利权人：UNIV NORTHWEST A&F;

专利标题：Method for synthesizing telithromycin key intermediate 5-deoaminyl-6-O-methylerythromycin

专利标题：SOLID PHARMACEUTICAL COMPOSITION COMPRISING TELITHROMYCIN

专利权人：AVENTIS PHARMA SA [FR];

THE INVENTION RELATES TO A SOLID PHARMACEUTICAL COM POSITION COMPRISING TELITHROMYCIN OR AN ADDITION SALT THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID, AS AN ACTIVE INGREDIENT, CHARACTERIZED IN THAT IT COMPRISES, RELATIVE TO THE TOTAL WEIGHT OF THE COMPOSITION: - TELITHROMYCIN, OR AN ADDITION SALT THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID, IN A PROPORTION OF TELITHROMYCIN OF BETWEEN 0.1 AND 80% BY WEIGHT, AND - AT LEAST ONE DILUENT HAVING A PLASTIC BEHAVI- OUR, IN A PROPORTION OF TO 50%...

专利标题：Globose cohesion body of [terisuromaishin], use to production of the production method and medicine shape for its medicine manufacture

The invention relates to spherical telithromycin clusters and to a method for the production thereof characterized in that a telithromycin crystal suspension is prepared said crystals are coated with a telithromycin insoluble phase which gradually crystallizes.The spherical telithromycin clusters are used in the preparation of micro-capsules.(From US6825218 B1)

当前查询条件: [药品] 包含 'Telithromycin '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US20130344151A1	2013/12/26	US14/014677	2013/8/30
专利标题：Solid pharmaceutical composition comprising telithromycin 专利权人：Aventis Pharma S.a.; The invention relates to a novel solid pharmaceutical composition of telithromycin which facilitates swallowing by the patient.

2. US2013344151A1	2013/12/26	US201314014677	2013/8/30
专利标题：SOLID PHARMACEUTICAL COMPOSITION COMPRISING TELITHROMYCIN 专利权人：AVENTIS PHARMA SA [FR]; The invention relates to a novel solid pharmaceutical composition of telithromycin which facilitates swallowing by the patient.

3. HU229075B1	2013/7/29	HU20020002842	2000/8/28
专利标题：Method for the production and use of spherical telithromycin clusters in the preparation of pharmaceutical forms 专利权人：Aventis Pharma S.a.;

4. CN102499936B	2013/6/26	CN20111392416	2011/12/1
专利标题：A kind of compound telithromycin nanoemulsion oral liquid and preparation method thereof 专利权人：Northwest A&f University;

5. JP5063368B2	2012/10/31	JP20070556635	2006/2/23
专利标题：Main invention of the solid medicine composition which 专利权人： Solid pharmaceutical composition (A) comprises telithromycin (I) (0.1-80 wt.%) or its acid addition salts as an active ingredient and a diluting agent (II) (10-50 wt.%) having plastic behavior. - ACTIVITY : Antibacterial. - MECHANISM OF ACTION : None given.

6. US8222380B2	2012/7/17	US12/159939	2007/1/4
专利标题：Amorphous telithromycin compound 专利权人：SANDOZ AG; The present invention relates to stable amorphous 3-De[(26-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyl)oxy]-1112-dideoxy-6-O-methyl-3-oxo-1211-[oxycarbonyl[[4-[4-(3-pyridinyl)-1H-imidazol-1-yl]butyl]imino]]erythromycin (telithromycin) methods for the preparation thereof the use of stable amorphous telithromycin in the treatment of bacterial infections and to pharmaceutical compositions comprising stable amorphous telithromycin.

7. CN102499936A	2012/6/20	CN20111392416	2011/12/1
专利标题：Compound telithromycin nanoemulsion oral liquid and preparation method thereof 专利权人：UNIV NORTHWEST A&F;

8. CN102417532A	2012/4/18	CN20111429285	2011/12/20
专利标题：Method for synthesizing telithromycin key intermediate 5-deoaminyl-6-O-methylerythromycin 专利权人：ZHEJIANG GUOBANG PHARMACEUTICAL CO LTD;

9. MY145394A	2012/2/15	MYPI20060710	2006/2/20
专利标题：SOLID PHARMACEUTICAL COMPOSITION COMPRISING TELITHROMYCIN 专利权人：AVENTIS PHARMA SA [FR]; THE INVENTION RELATES TO A SOLID PHARMACEUTICAL COM POSITION COMPRISING TELITHROMYCIN OR AN ADDITION SALT THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID, AS AN ACTIVE INGREDIENT, CHARACTERIZED IN THAT IT COMPRISES, RELATIVE TO THE TOTAL WEIGHT OF THE COMPOSITION: - TELITHROMYCIN, OR AN ADDITION SALT THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID, IN A PROPORTION OF TELITHROMYCIN OF BETWEEN 0.1 AND 80% BY WEIGHT, AND - AT LEAST ONE DILUENT HAVING A PLASTIC BEHAVI- OUR, IN A PROPORTION OF TO 50%...

10. JP4871467B2	2012/2/8	JP20010518723	2000/8/28
专利标题：Globose cohesion body of [terisuromaishin], use to production of the production method and medicine shape for its medicine manufacture 专利权人： The invention relates to spherical telithromycin clusters and to a method for the production thereof characterized in that a telithromycin crystal suspension is prepared said crystals are coated with a telithromycin insoluble phase which gradually crystallizes.The spherical telithromycin clusters are used in the preparation of micro-capsules.(From US6825218 B1)

下载范围

下载内容